[go: up one dir, main page]

CN112043893A - In-vitro citric acid anticoagulation hemodialysis control device, system and method - Google Patents

In-vitro citric acid anticoagulation hemodialysis control device, system and method Download PDF

Info

Publication number
CN112043893A
CN112043893A CN202010975237.7A CN202010975237A CN112043893A CN 112043893 A CN112043893 A CN 112043893A CN 202010975237 A CN202010975237 A CN 202010975237A CN 112043893 A CN112043893 A CN 112043893A
Authority
CN
China
Prior art keywords
hemodialysis
module
infusion pump
control
citrate anticoagulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010975237.7A
Other languages
Chinese (zh)
Inventor
李青
聂静雯
蔡亚萍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
First Affiliated Hospital of Kunming Medical University
Original Assignee
First Affiliated Hospital of Kunming Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by First Affiliated Hospital of Kunming Medical University filed Critical First Affiliated Hospital of Kunming Medical University
Priority to CN202010975237.7A priority Critical patent/CN112043893A/en
Publication of CN112043893A publication Critical patent/CN112043893A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1621Constructional aspects thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601Control or regulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • GPHYSICS
    • G05CONTROLLING; REGULATING
    • G05BCONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
    • G05B19/00Program-control systems
    • G05B19/02Program-control systems electric
    • G05B19/04Program control other than numerical control, i.e. in sequence controllers or logic controllers
    • G05B19/042Program control other than numerical control, i.e. in sequence controllers or logic controllers using digital processors
    • G05B19/0423Input/output
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M2005/14208Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Emergency Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Automation & Control Theory (AREA)
  • General Physics & Mathematics (AREA)
  • External Artificial Organs (AREA)

Abstract

本发明公开一种体外枸橼酸抗凝血液透析液透析控制装置、系统及方法,包括一体成型的血液透析机和输液泵、连接血液透析机和输液泵的管道组件、用于进行控制及交互的控制部;通过控制部的数据采集模块将采集血液透析机和输液泵的控制模块的数据信息,通过数模转化模块转化后输入处理器模块进行处理计算,模式选择模块可设定并对血液透析机、输液泵进行控制;本发明的体外枸橼酸抗凝血液透析液透析控制装置、系统及方法,有效的将血液透析机和输液泵结合,并通过集成的控制系统进行交互与控制,将血液透析系统及枸橼酸泵入系统结合,便于使用局部枸橼酸抗凝技术血液透析推广应用。

Figure 202010975237

The invention discloses an extracorporeal citrate anticoagulation hemodialysis control device, system and method, comprising an integrally formed hemodialysis machine and an infusion pump, a pipeline assembly connecting the hemodialysis machine and the infusion pump, and a control and interaction The control part of the control part; the data information of the control module of the hemodialysis machine and the infusion pump will be collected through the data acquisition module of the control part, and then converted by the digital-to-analog conversion module and input to the processor module for processing and calculation, and the mode selection module can be set and the blood The dialysis machine and the infusion pump are controlled; the external citrate anticoagulation hemodialysis fluid dialysis control device, system and method of the present invention effectively combine the hemodialysis machine and the infusion pump, and conduct interaction and control through the integrated control system, The combination of the hemodialysis system and the citric acid pumping system is convenient for the promotion and application of hemodialysis using local citrate anticoagulation technology.

Figure 202010975237

Description

一种体外枸橼酸抗凝血液透析控制装置、系统及方法A kind of extracorporeal citrate anticoagulation hemodialysis control device, system and method

技术领域technical field

本发明涉及血液透析技术领域,具体的涉及一种体外枸橼酸抗凝血液透析控制装置、系统及方法。The invention relates to the technical field of hemodialysis, in particular to an extracorporeal citrate anticoagulation hemodialysis control device, system and method.

背景技术Background technique

血液透析治疗中需要辅助运用抗凝剂来确保体外循环功能正常,抗凝是血液透析中的重要环节,以肝素钠药物为主,效果显著;但是对于有出血倾向患者而言,肝素钠抗凝期间易加重出血倾向,近年来,临床开始将体外枸橼酸抗凝技术用于血液透析中,特别是针对有明显出血倾向,围手术期需要血透的患者,预防出血上意义重大;在血液透析中使用枸橼酸体外抗凝,在凝血机制中作用显著,在血液透析期间的循环管路中使用枸橼酸,能结合钙离子,形成的枸橼酸钙复合物,降低钙离子浓度,延长凝血时间,降低凝血发生率。血透结束时,补充钙离子,预防低钙血症的发生,提高血液透析效果;研究表明,使用体外枸橼酸抗凝技术血液透析,安全可靠、出血风险明显较肝素体内抗凝小,值得临床推广应用,特别适用于临床中有明确出血倾向、术后透析患者。In hemodialysis treatment, it is necessary to use anticoagulants to ensure the normal function of extracorporeal circulation. Anticoagulation is an important part of hemodialysis. During the period, it is easy to aggravate the bleeding tendency. In recent years, in vitro citrate anticoagulation technology has been used in hemodialysis, especially for patients with obvious bleeding tendency who need hemodialysis in the perioperative period. It is of great significance to prevent bleeding; The use of citric acid for in vitro anticoagulation in dialysis plays a significant role in the coagulation mechanism. The use of citric acid in the circulation pipeline during hemodialysis can bind calcium ions to form a calcium citrate complex, which reduces the concentration of calcium ions. Prolong blood clotting time and reduce the incidence of blood clotting. At the end of hemodialysis, calcium ions should be added to prevent the occurrence of hypocalcemia and improve the effect of hemodialysis. Studies have shown that the use of extracorporeal citrate anticoagulation technology for hemodialysis is safe and reliable, and the bleeding risk is significantly lower than heparin in vivo anticoagulation. Clinical promotion and application, especially for patients with clear bleeding tendency and postoperative dialysis.

目前,体外枸橼酸抗凝血液透析技术在应用时,因血液透析设备不具备泵注的功能,在实际操作过程中,需要采用额外的输液泵对枸橼酸进行泵入及监测,导致该技术在运用过程操作不便,血液透析设备不能和枸橼酸泵入设备有效结合,因此,申请人设计一种体外枸橼酸抗凝血液透析控制装置、系统及方法。At present, in the application of extracorporeal citrate anticoagulation hemodialysis technology, since the hemodialysis equipment does not have the function of pumping, in the actual operation process, an additional infusion pump needs to be used to pump and monitor the citrate, resulting in this The technology is inconvenient to operate during the application process, and the hemodialysis equipment cannot be effectively combined with the citric acid pumping equipment. Therefore, the applicant designs an extracorporeal citrate anticoagulation hemodialysis control device, system and method.

发明内容SUMMARY OF THE INVENTION

针对现有技术存在的上述问题,本发明提供了一种体外枸橼酸抗凝血液透析控制装置、系统及方法,将血液透析系统及枸橼酸泵入系统结合,便于使用局部枸橼酸抗凝技术血液透析推广应用。In view of the above problems existing in the prior art, the present invention provides an extracorporeal citrate anticoagulation hemodialysis control device, system and method, which combine the hemodialysis system and the citric acid pumping system to facilitate the use of topical citrate anticoagulation. Promotion and application of coagulation technology in hemodialysis.

为实现上述技术目的,达到上述技术效果,本发明是通过以下技术方案实现:In order to realize the above-mentioned technical purpose and achieve the above-mentioned technical effect, the present invention is realized through the following technical solutions:

一种体外枸橼酸抗凝血液透析控制装置,包括血液透析机、输液泵、管道组件和控制部,所述血液透析机和输液泵一体成型,输液泵集成安装于血液透析机两侧,血液透析机和输液泵通过管道组件与各通道连接,所述血液透析机和输液泵的控制模块集成于控制部,并通过交互模块实现交互及信息反馈。An extracorporeal citrate anticoagulation hemodialysis control device, comprising a hemodialysis machine, an infusion pump, a pipeline assembly and a control part, the hemodialysis machine and the infusion pump are integrally formed, the infusion pump is integrally installed on both sides of the hemodialysis machine, and the blood The dialysis machine and the infusion pump are connected to each channel through pipeline components, the control modules of the hemodialysis machine and the infusion pump are integrated in the control part, and interaction and information feedback are realized through the interaction module.

进一步的,所述交互模块包括显示模块、输入模块和语音模块,各模块均与控制部连接;Further, the interaction module includes a display module, an input module and a voice module, each of which is connected to the control unit;

所述显示模块为触控显示屏,分屏显示血液透析机、输液泵,同时进行模式选择及交互及信息反馈。The display module is a touch display screen, which displays the hemodialysis machine and the infusion pump in a split screen, and simultaneously performs mode selection, interaction and information feedback.

进一步的,所述血液透析机和输液泵的管道组件各自设有标识。Further, the pipeline components of the hemodialysis machine and the infusion pump are each provided with a mark.

进一步的,所述输液泵至少包括安装于血液透析机左右侧的各一个。Further, the infusion pump includes at least one installed on the left and right sides of the hemodialysis machine.

本发明的另一目的在于,提供一种体外枸橼酸抗凝血液透析控制装置的控制系统;Another object of the present invention is to provide a control system of an extracorporeal citrate anticoagulation hemodialysis control device;

所述控制系统包括:The control system includes:

数据采集模块:用于采集血液透析机和输液泵的控制模块的数据信息;Data acquisition module: used to collect the data information of the control module of the hemodialysis machine and the infusion pump;

数模转化模块:用于将采集的数据信息进行转化;Digital-to-analog conversion module: used to convert the collected data information;

处理器模块:用于根据预设程序、参数对数模转化模块转化后输入处理器模块进行处理计算;Processor module: used to process and calculate the input processor module after the conversion of the digital-to-analog conversion module according to the preset program and parameters;

模式选择模块:用于设定并对血液透析机、输液泵进行控制;Mode selection module: used to set and control the hemodialysis machine and infusion pump;

人机交互模块:用于实现人机交互。Human-computer interaction module: used to realize human-computer interaction.

进一步的,所述控制系统的数据采集模块将采集血液透析机和输液泵的控制模块的数据信息,通过数模转化模块转化后输入处理器模块进行处理计算,模式选择模块可设定并对血液透析机、输液泵进行控制。Further, the data acquisition module of the control system will collect the data information of the control module of the hemodialysis machine and the infusion pump, and input it into the processor module for processing and calculation after conversion by the digital-to-analog conversion module. Dialysis machine and infusion pump are controlled.

本发明的另一目的在于,提供一种体外枸橼酸抗凝血液透析控制方法;Another object of the present invention is to provide an in vitro citrate anticoagulation hemodialysis control method;

所述控制方法包括:The control method includes:

手动控制:根据血液透析和局部枸橼酸抗凝泵入参数要求,通过人机交互模块对血液透析机、输液泵进行控制;Manual control: According to the requirements of hemodialysis and local citrate anticoagulation pump input parameters, the hemodialysis machine and infusion pump are controlled through the human-computer interaction module;

自动控制:根据预设的模式选择模块,进行模式选择对血液透析机、输液泵进行控制。Automatic control: According to the preset mode selection module, the mode selection is performed to control the hemodialysis machine and the infusion pump.

本发明的另一目的在于,提供一种体外枸橼酸抗凝血液透析控制装置、系统及方法在体外枸橼酸抗凝血液透析技术中的应用。Another object of the present invention is to provide the application of an extracorporeal citrate anticoagulation hemodialysis control device, system and method in the extracorporeal citrate anticoagulation hemodialysis technology.

本发明的有益效果:Beneficial effects of the present invention:

本发明的体外枸橼酸抗凝血液透析控制装置、系统及方法,包括一体成型的血液透析机和输液泵、连接血液透析机和输液泵的管道组件、用于进行控制及交互的控制部;通过控制部的数据采集模块将采集血液透析机和输液泵的控制模块的数据信息,通过数模转化模块转化后输入处理器模块进行处理计算,模式选择模块可设定并对血液透析机、输液泵进行控制;The extracorporeal citrate anticoagulation hemodialysis control device, system and method of the present invention include an integrally formed hemodialysis machine and an infusion pump, a pipeline assembly connecting the hemodialysis machine and the infusion pump, and a control unit for control and interaction; The data information of the control module of the hemodialysis machine and the infusion pump will be collected through the data acquisition module of the control unit, and then converted by the digital-to-analog conversion module and input to the processor module for processing and calculation. control the pump;

本发明的体外枸橼酸抗凝血液透析控制装置、系统及方法,有效的将血液透析机和输液泵结合,并通过集成的控制系统进行交互与控制,将血液透析系统及枸橼酸泵入系统结合,便于使用局部枸橼酸抗凝技术血液透析推广应用。The extracorporeal citrate anticoagulation hemodialysis control device, system and method of the present invention effectively combine the hemodialysis machine and the infusion pump, interact and control through the integrated control system, and pump the hemodialysis system and citric acid into the The combination of the system is convenient for the promotion and application of hemodialysis using local citrate anticoagulation technology.

当然,实施本发明的任一产品并不一定需要同时达到以上所述的所有优点。Of course, it is not necessary for any product embodying the present invention to achieve all of the above-described advantages simultaneously.

附图说明Description of drawings

为了更清楚地说明本发明实施例的技术方案,下面将对实施例描述所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to illustrate the technical solutions of the embodiments of the present invention more clearly, the following briefly introduces the accompanying drawings used in the description of the embodiments. Obviously, the drawings in the following description are only some embodiments of the present invention. For those of ordinary skill in the art, other drawings can also be obtained from these drawings without any creative effort.

图1为本发明实施例所述体外枸橼酸抗凝血液透析控制装置的结构示意图;1 is a schematic structural diagram of an in vitro citrate anticoagulation hemodialysis control device according to an embodiment of the present invention;

图2为本发明实施例所述体外枸橼酸抗凝血液透析控制装置的控制示意图;Fig. 2 is the control schematic diagram of the extracorporeal citrate anticoagulation hemodialysis control device according to the embodiment of the present invention;

图3为本发明实施例所述体外枸橼酸抗凝血液透析控制装置的控制原理框图;3 is a block diagram of the control principle of the in vitro citrate anticoagulation hemodialysis control device according to the embodiment of the present invention;

附图中,各标号所代表的部件名称如下:In the accompanying drawings, the names of the components represented by each number are as follows:

1-血液透析机,2-输液泵。1- Hemodialysis machine, 2- Infusion pump.

具体实施方式Detailed ways

下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其它实施例,都属于本发明保护的范围。The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, but not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts shall fall within the protection scope of the present invention.

实施例1Example 1

如图1所示As shown in Figure 1

一种体外枸橼酸抗凝血液透析控制装置,包括血液透析机、输液泵、管道组件和控制部,所述血液透析机和输液泵一体成型,输液泵集成安装于血液透析机两侧,血液透析机和输液泵通过管道组件与各通道连接,所述血液透析机和输液泵的控制模块集成于控制部,并通过交互模块实现交互及信息反馈。An extracorporeal citrate anticoagulation hemodialysis control device, comprising a hemodialysis machine, an infusion pump, a pipeline assembly and a control part, the hemodialysis machine and the infusion pump are integrally formed, the infusion pump is integrally installed on both sides of the hemodialysis machine, and the blood The dialysis machine and the infusion pump are connected to each channel through pipeline components, the control modules of the hemodialysis machine and the infusion pump are integrated in the control part, and interaction and information feedback are realized through the interaction module.

所述交互模块包括显示模块、输入模块和语音模块,各模块均与控制部连接;The interaction module includes a display module, an input module and a voice module, each of which is connected to the control unit;

所述显示模块为触控显示屏,分屏显示血液透析机、输液泵,同时进行模式选择及交互及信息反馈。The display module is a touch display screen, which displays the hemodialysis machine and the infusion pump in a split screen, and simultaneously performs mode selection, interaction and information feedback.

所述血液透析机和输液泵的管道组件各自设有标识。The pipeline components of the hemodialysis machine and the infusion pump are respectively provided with signs.

所述输液泵至少包括安装于血液透析机左右侧的各一个。The infusion pump includes at least one installed on the left and right sides of the hemodialysis machine.

实施例2Example 2

一种体外枸橼酸抗凝血液透析控制装置的控制系统;A control system of an extracorporeal citrate anticoagulation hemodialysis control device;

所述控制系统包括:The control system includes:

数据采集模块:用于采集血液透析机和输液泵的控制模块的数据信息;Data acquisition module: used to collect the data information of the control module of the hemodialysis machine and the infusion pump;

数模转化模块:用于将采集的数据信息进行转化;Digital-to-analog conversion module: used to convert the collected data information;

处理器模块:用于根据预设程序、参数对数模转化模块转化后输入处理器模块进行处理计算;Processor module: used to process and calculate the input processor module after the conversion of the digital-to-analog conversion module according to the preset program and parameters;

模式选择模块:用于设定并对血液透析机、输液泵进行控制;Mode selection module: used to set and control the hemodialysis machine and infusion pump;

人机交互模块:用于实现人机交互。Human-computer interaction module: used to realize human-computer interaction.

所述控制系统的数据采集模块将采集血液透析机和输液泵的控制模块的数据信息,通过数模转化模块转化后输入处理器模块进行处理计算,模式选择模块可设定并对血液透析机、输液泵进行控制。The data acquisition module of the control system will collect the data information of the control module of the hemodialysis machine and the infusion pump, and then input it into the processor module for processing and calculation after conversion by the digital-to-analog conversion module. Control the infusion pump.

实施例3Example 3

一种体外枸橼酸抗凝血液透析控制方法;An extracorporeal citrate anticoagulation hemodialysis control method;

所述控制方法包括:The control method includes:

手动控制:根据血液透析和局部枸橼酸抗凝泵入参数要求,通过人机交互模块对血液透析机、输液泵进行控制;Manual control: According to the requirements of hemodialysis and local citrate anticoagulation pump input parameters, the hemodialysis machine and infusion pump are controlled through the human-computer interaction module;

自动控制:根据预设的模式选择模块,进行模式选择对血液透析机、输液泵进行控制。Automatic control: According to the preset mode selection module, the mode selection is performed to control the hemodialysis machine and the infusion pump.

实施例4Example 4

一种体外枸橼酸抗凝血液透析控制装置、系统及方法在体外枸橼酸抗凝血液透析技术中的应用。Application of an extracorporeal citrate anticoagulation hemodialysis control device, system and method in extracorporeal citrate anticoagulation hemodialysis technology.

本发明的体外枸橼酸抗凝血液透析控制装置、系统及方法,包括一体成型的血液透析机和输液泵、连接血液透析机和输液泵的管道组件、用于进行控制及交互的控制部;通过控制部的数据采集模块将采集血液透析机和输液泵的控制模块的数据信息,通过数模转化模块转化后输入处理器模块进行处理计算,模式选择模块可设定并对血液透析机、输液泵进行控制;The extracorporeal citrate anticoagulation hemodialysis control device, system and method of the present invention include an integrally formed hemodialysis machine and an infusion pump, a pipeline assembly connecting the hemodialysis machine and the infusion pump, and a control unit for control and interaction; The data information of the control module of the hemodialysis machine and the infusion pump will be collected through the data acquisition module of the control unit, and then converted by the digital-to-analog conversion module and input to the processor module for processing and calculation. control the pump;

本发明的体外枸橼酸抗凝血液透析控制装置、系统及方法,有效的将血液透析机和输液泵结合,并通过集成的控制系统进行交互与控制,将血液透析系统及枸橼酸泵入系统结合,便于使用局部枸橼酸抗凝技术血液透析推广应用。The extracorporeal citrate anticoagulation hemodialysis control device, system and method of the present invention effectively combine the hemodialysis machine and the infusion pump, interact and control through the integrated control system, and pump the hemodialysis system and citric acid into the The combination of the system is convenient for the promotion and application of hemodialysis using local citrate anticoagulation technology.

在本说明书的描述中,参考术语“一个实施例”、“示例”、“具体示例”等的描述意指结合该实施例或示例描述的具体特征、结构、材料或者特点包含于本发明的至少一个实施例或示例中。在本说明书中,对上述术语的示意性表述不一定指的是相同的实施例或示例。而且,描述的具体特征、结构、材料或者特点可以在任何的一个或多个实施例或示例中以合适的方式结合。In the description of this specification, description with reference to the terms "one embodiment," "example," "specific example," etc. means that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one aspect of the present invention. in one embodiment or example. In this specification, schematic representations of the above terms do not necessarily refer to the same embodiment or example. Furthermore, the particular features, structures, materials or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.

以上公开的本发明优选实施例只是用于帮助阐述本发明。优选实施例并没有详尽叙述所有的细节,也不限制该发明仅为所述的具体实施方式。显然,根据本说明书的内容,可作很多的修改和变化。本说明书选取并具体描述这些实施例,是为了更好地解释本发明的原理和实际应用,从而使所属技术领域技术人员能很好地理解和利用本发明。本发明仅受权利要求书及其全部范围和等效物的限制。The above-disclosed preferred embodiments of the present invention are provided only to help illustrate the present invention. The preferred embodiments do not exhaust all the details, nor do they limit the invention to only the described embodiments. Obviously, many modifications and variations are possible in light of the contents of this specification. These embodiments are selected and described in this specification in order to better explain the principles and practical applications of the present invention, so that those skilled in the art can well understand and utilize the present invention. The present invention is to be limited only by the claims and their full scope and equivalents.

Claims (8)

1.一种体外枸橼酸抗凝血液透析控制装置,其特征在于:包括血液透析机、输液泵、管道组件和控制部,所述血液透析机和输液泵一体成型,输液泵集成安装于血液透析机两侧,血液透析机和输液泵通过管道组件与各通道连接,所述血液透析机和输液泵的控制模块集成于控制部,并通过交互模块实现交互及信息反馈。1. an external citrate anticoagulation hemodialysis control device, is characterized in that: comprise hemodialysis machine, infusion pump, pipeline assembly and control part, described hemodialysis machine and infusion pump are integrally formed, and infusion pump is integrated and installed in blood On both sides of the dialysis machine, the hemodialysis machine and the infusion pump are connected to each channel through pipeline components. The control modules of the hemodialysis machine and the infusion pump are integrated in the control unit, and interaction and information feedback are realized through the interactive module. 2.如权利要求1所述的体外枸橼酸抗凝血液透析控制装置,其特征在于:所述交互模块包括显示模块、输入模块和语音模块,各模块均与控制部连接;2. The external citrate anticoagulation hemodialysis control device as claimed in claim 1, wherein the interactive module comprises a display module, an input module and a voice module, and each module is connected with the control unit; 所述显示模块为触控显示屏,分屏显示血液透析机、输液泵,同时进行模式选择及交互及信息反馈。The display module is a touch display screen, which displays the hemodialysis machine and the infusion pump in a split screen, and simultaneously performs mode selection, interaction and information feedback. 3.如权利要求1所述的体外枸橼酸抗凝血液透析控制装置,其特征在于:所述血液透析机和输液泵的管道组件各自设有标识。3 . The extracorporeal citrate anticoagulation hemodialysis control device according to claim 1 , wherein the pipeline components of the hemodialysis machine and the infusion pump are each provided with a mark. 4 . 4.如权利要求1所述的体外枸橼酸抗凝血液透析控制装置,其特征在于:所述输液泵至少包括安装于血液透析机左右侧的各一个。4 . The extracorporeal citrate anticoagulation hemodialysis control device according to claim 1 , wherein the infusion pump at least comprises one installed on the left and right sides of the hemodialysis machine. 5 . 5.一种如权利要求1-4任意一项所述的体外枸橼酸抗凝血液透析控制装置的控制系统,其特征在于:5. A control system of the extracorporeal citrate anticoagulation hemodialysis control device according to any one of claims 1-4, wherein: 所述控制系统包括:The control system includes: 数据采集模块:用于采集血液透析机和输液泵的控制模块的数据信息;Data acquisition module: used to collect the data information of the control module of the hemodialysis machine and the infusion pump; 数模转化模块:用于将采集的数据信息进行转化;Digital-to-analog conversion module: used to convert the collected data information; 处理器模块:用于根据预设程序、参数对数模转化模块转化后输入处理器模块进行处理计算;Processor module: used to process and calculate the input processor module after the conversion of the digital-to-analog conversion module according to the preset program and parameters; 模式选择模块:用于设定并对血液透析机、输液泵进行控制;Mode selection module: used to set and control the hemodialysis machine and infusion pump; 人机交互模块:用于实现人机交互。Human-computer interaction module: used to realize human-computer interaction. 6.如权利要求5所述的体外枸橼酸抗凝血液透析控制装置的控制系统,其特征在于:所述控制系统的数据采集模块将采集血液透析机和输液泵的控制模块的数据信息,通过数模转化模块转化后输入处理器模块进行处理计算,模式选择模块可设定并对血液透析机、输液泵进行控制。6. The control system of the external citrate anticoagulation hemodialysis control device as claimed in claim 5, wherein the data acquisition module of the control system will collect the data information of the control module of the hemodialysis machine and the infusion pump, After conversion by the digital-to-analog conversion module, it is input into the processor module for processing and calculation, and the mode selection module can be set and controlled for the hemodialysis machine and the infusion pump. 7.一种如权利要求6所述的体外枸橼酸抗凝血液透析控制装置的控制系统,其特征在于:7. A control system of an extracorporeal citrate anticoagulation hemodialysis control device as claimed in claim 6, wherein: 所述体外枸橼酸抗凝血液透析液透析控制方法包括:The in vitro citrate anticoagulation hemodialysate dialysis control method includes: 手动控制:根据血液透析和局部枸橼酸抗凝泵入参数要求,通过人机交互模块对血液透析机、输液泵进行控制;Manual control: According to the requirements of hemodialysis and local citrate anticoagulation pump input parameters, the hemodialysis machine and infusion pump are controlled through the human-computer interaction module; 自动控制:根据预设的模式选择模块,进行模式选择对血液透析机、输液泵进行控制。Automatic control: According to the preset mode selection module, the mode selection is performed to control the hemodialysis machine and the infusion pump. 8.一种体外枸橼酸抗凝血液透析控制装置、系统及方法在体外枸橼酸抗凝血液透析液透析技术中的应用。8. Application of an extracorporeal citrate anticoagulation hemodialysis control device, system and method in extracorporeal citrate anticoagulation hemodialysis fluid dialysis technology.
CN202010975237.7A 2020-09-16 2020-09-16 In-vitro citric acid anticoagulation hemodialysis control device, system and method Pending CN112043893A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010975237.7A CN112043893A (en) 2020-09-16 2020-09-16 In-vitro citric acid anticoagulation hemodialysis control device, system and method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010975237.7A CN112043893A (en) 2020-09-16 2020-09-16 In-vitro citric acid anticoagulation hemodialysis control device, system and method

Publications (1)

Publication Number Publication Date
CN112043893A true CN112043893A (en) 2020-12-08

Family

ID=73603001

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010975237.7A Pending CN112043893A (en) 2020-09-16 2020-09-16 In-vitro citric acid anticoagulation hemodialysis control device, system and method

Country Status (1)

Country Link
CN (1) CN112043893A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050085760A1 (en) * 2003-10-15 2005-04-21 Ware Lee C. Medical fluid therapy flow balancing and synchronization system
US20100121246A1 (en) * 2008-11-03 2010-05-13 Transvivo Inc. Modular hemofiltration apparatus with interactive operator instructions and control system
CN104471579A (en) * 2013-03-15 2015-03-25 甘布罗伦迪亚肾脏产品公司 Extracorporeal blood treatment fluid interface
CN107045588A (en) * 2016-02-08 2017-08-15 B·布莱恩·阿维图姆股份公司 Method for setting fluid processing medical equipment

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050085760A1 (en) * 2003-10-15 2005-04-21 Ware Lee C. Medical fluid therapy flow balancing and synchronization system
US20100121246A1 (en) * 2008-11-03 2010-05-13 Transvivo Inc. Modular hemofiltration apparatus with interactive operator instructions and control system
CN104471579A (en) * 2013-03-15 2015-03-25 甘布罗伦迪亚肾脏产品公司 Extracorporeal blood treatment fluid interface
CN107045588A (en) * 2016-02-08 2017-08-15 B·布莱恩·阿维图姆股份公司 Method for setting fluid processing medical equipment

Similar Documents

Publication Publication Date Title
Lok et al. Trisodium citrate 4%—an alternative to heparin capping of haemodialysis catheters
Vemuri et al. Association between acute kidney injury during invasive mechanical ventilation and ICU outcomes and respiratory system mechanics
Yuen et al. The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients
Boschee et al. Indications and outcomes in children receiving renal replacement therapy in pediatric intensive care
WO2017045088A1 (en) Fully-automatic regional citrate anticoagulation machine
CN102309785A (en) Method for improving regional citric acid anticoagulation
Gruenwald et al. Randomized, controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass
Modrau et al. Impact of minimally invasive extracorporeal circulation on coagulation—a randomized trial
Cheng et al. Anticoagulation during haemodialysis using a citrate-enriched dialysate: a feasibility study
Baldwin et al. Therapeutic plasma exchange in the intensive care unit and with the critically ill, a focus on clinical nursing considerations
CN112043893A (en) In-vitro citric acid anticoagulation hemodialysis control device, system and method
Lucchi et al. Activation of coagulation during hemodialysis: effect of blood lines alone and whole extracorporeal circuit
Leung et al. Citrate vs. acetate dialysate on intradialytic heparin dose: a double blind randomized crossover study
CN110960742B (en) RCA control system and RCA target control infusion pump
WO2018040324A1 (en) Citrate anticoagulation device and application thereof
Mukherjee et al. Transudative chylothorax: an uncommon illness due to a common cause
CN115910280B (en) Auxiliary system and method for anticoagulation of CRRT (China railway track time) local citric acid
CN111905170A (en) System and equipment for controlling blood oxygen saturation in VV-ECMO mode
Arnold et al. Integration of sustained low‐efficiency dialysis into extracorporeal membrane oxygenation circuit in critically ill COVID‐19 patients: A feasibility study
Li et al. Changes in coagulation factor XII and its function during aortic arch surgery for acute aortic dissection—a prospective observational study
Fang et al. The application value of systematic nursing in severe acute pancreatitis patients undergoing blood purification treatment
Wang et al. Non-Thyroidal illness syndrome–associated multiorgan dysfunction after surgical repair of type A aortic dissection
Connors Preventing pregnancy loss
CN204972446U (en) Binary channels replacement liquid input continuity blood clarification plant
CN221636892U (en) Pump pipe joint for extracorporeal blood purifying and circulating pipeline

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20201208

RJ01 Rejection of invention patent application after publication